Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D31NIC
|
|||
| Drug Name |
PDS0101
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Head and neck cancer [ICD-11: 2D42; ICD-9: 199] | Phase 2 | [1] | |
| Company |
PDS Biotechnology
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04260126) Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC (VERSATILE002). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.